Crystals And Catalysts

Today may be a normal day for all of us, we get up to go to work, university or school and carry out our daily routine… but this is most of us - not all of us. We may be the lucky ones who have not been cursed with dreaded migraines, causing the most unfortunate of us to seek refuge in our bedrooms like owls who only appear during the night. Robyn*, a migraine sufferer has seen her mother and her auntie go through a difficult time with migraines and at the age of 40, she became a victim herself. On the days she yearned to be outside, sociable, proactive, she was imprisoned in a dark room, no sound, no lights and no smells (they all make her headaches worse and make her throw up). She’s tried a lot of medications, none seem to at least shorten the time period that the dark cloud takes over.  But now, thanks to science, she may be able to experience a brighter future. This is because of a new advancement in migraine history. The first migraine drug to prove successful in 20 years

Whether it's stress or spending too much time focusing on computer/laptop screens we’re all susceptible to experiencing migraines and some people suffer from them even more than others; and we have heard many recommendations on how to prevent migraines, such as drinking plenty of water, but not the actual reasons why we get migraines. Researchers at Cincinnati Children's Hospital Medical Centre have found that a high percentage of children, teens and young adults with migraines appear to have mild deficiencies in vitamin D, riboflavin and coenzyme Q10. It’s possible that these deficiencies may play a role in the onset of migraines but this is still unclear, based on existing studies. In this study, the researchers’ trial drew from a database that looks at vitamin D, riboflavin and coenzyme Q10, all of which are all associated with migraines to some degree, and this has been reported in many previous research studies, some studies have even conflicted each other. Most of